Gene therapy shows 75% slowing of Huntington’s disease progression in early trial
Health • 5 months ago
UniQure's AMT-130 demonstrates substantial slowing in a small Phase I/II study; FDA submission planned for 2026.
Health News
New Ebola outbreak in Congo kills dozens as donors urged to fund response
Health • 5 months ago
WHO reports 57 cases and 35 deaths since Sept. 4; funding gaps threaten containment in Kasai province
New Ebola outbreak in Congo kills dozens as donors urged to fund response
Health • 5 months ago
Kasai province outbreak in southern Congo reports 57 cases and 35 deaths; officials warn funding gaps threaten containment
Trump extends Georgia health insurance program with work requirements, despite red tape findings
Health • 5 months ago
Georgia extends Pathways to Coverage for 15 months, with reporting changes and new eligibility rules, as critics warn of coverage loss under work requirements.
Trump extends Georgia health insurance program with work requirements, despite red tape findings
Health • 5 months ago
Georgia will keep Pathways to Coverage through December 2026 with adjusted reporting rules; starting in 2027, some adults seeking Medicaid may face an 80-hour monthly work or activity requirement.
New Ebola outbreak in Congo kills dozens as funding gaps hamper response
Health • 5 months ago
Kasai province outbreak prompts urgent appeals for funds as health facilities strain under surge
14-year-old dies after secret breast surgery and butt lift in Durango; surgeon under investigation
Health • 5 months ago
Father alleges a cover-up as authorities probe negligent homicide; physician suspended amid investigation
US circumcision rate hits record low as foreskin restoration movement grows
Health • 5 months ago
Newborn circumcision rates fall to 49.3%, while some adult men pursue non-surgical restoration; medical experts urge caution amid uncertain outcomes.
Oral GLP-1 weight-loss pill shows promise as potential replacement for Ozempic and Wegovy
Health • 5 months ago
Phase 3 data for orforglipron indicate meaningful weight loss and cardiometabolic benefits; Lilly eyes regulatory submission with potential FDA action by 2026